Gloshell
Ingredients

Ingredient Dictionary

BARIUM HEXAFERRITE

Molecular structure

Definition

US FDA substance register · UNII 4HT629NL8B · registered name BARIUM HEXAFERRITE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

No declared roleNOT REPORTED

Safety & regulatory references

Banned
Argentina · ASEAN · Brazil · China · European Union · South Korea · Taiwan

Source: MFDS (Korea) cosmetic regulatory information

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

Restriction II/46 · Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Names & identifiers

BARIUM HEXAFERRITEINCI바륨헥사페라이트Korean label name (MFDS standard)
CAS No.chemical registry number
12047-11-9
EC No.EU chemical inventory number
234-974-5
DTXSIDUS EPA chemical ID
DTXSID20923429

Measured properties

Appearance
solid
Odour
odourless
Melting/freezing point
&amp, gt, 450 ℃
Flammability (solid, gas)
not flammable
Water solubility
&amp, lt, 0.002 ㎎/ℓ (20℃, pH: 9.3~10.1)
Relative density
5.87 (20℃)
Auto-ignition temperature
&amp, gt, 450 ℃
Molecular weight
1111.54

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: KOSHA safety data sheets (Korea)

What products actually use it for

What the 1 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • No specific technical function1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

3 skin studies and 0 eye studies are on record.

Classed as low2

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • Ambiguous
    skin corrosion: in vitro / ex vivo · Screening · other guideline: EU method B.40bis according to other guideline: OECD 431 Guideline according to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin corrosion: in vitro / ex vivo · Screening · other guideline: EU Method B.46 according to

Source: US EPA CompTox dashboard

Related literature

Linked databases 12